tpst1 Antibody

What is TPST1 and what biological role does it play?

TPST1 (tyrosylprotein sulfotransferase 1) is one of two Golgi-resident enzymes (along with TPST2) that catalyze the transfer of sulfate to tyrosine residues in secreted and transmembrane proteins . This post-translational modification is crucial for protein-protein interactions in several well-defined biological systems. Research indicates that TPST1 and TPST2 have distinct macromolecular substrate specificities, suggesting they may serve different biological functions . TPST1 has a calculated molecular weight of 42 kDa (370 amino acids) and is coded by the TPST1 gene (ID: 8460) .

What types of TPST1 antibodies are available for research applications?

TPST1 antibodies are available in multiple formats including:

• Unconjugated primary antibodies from various hosts (predominantly rabbit)

• Conjugated antibodies with different tags:

  • HRP-conjugated for enhanced chemiluminescent detection

  • FITC-conjugated for fluorescence applications

  • Biotin-conjugated for streptavidin-based detection systems

Most commercially available antibodies are polyclonal, targeting different epitopes of the TPST1 protein, including N-terminal, C-terminal, and internal regions . For example, some antibodies target amino acids 336-366 at the C-terminus, while others target regions such as AA 283-370 or AA 165-260 .

What is the difference between anti-TPST1 and anti-sulfotyrosine antibodies?

Anti-TPST1 antibodies specifically detect the TPST1 enzyme itself, regardless of its activity state . In contrast, anti-sulfotyrosine antibodies (such as PSG2) detect the product of TPST activity – proteins containing sulfated tyrosine residues – regardless of which TPST isoform performed the sulfation . Anti-sulfotyrosine antibodies bind with high affinity and specificity to sulfotyrosine residues in peptides and proteins independently of sequence context, making them valuable for detecting all tyrosine-sulfated proteins in complex biological samples . While anti-TPST1 antibodies help study the expression and localization of the enzyme, anti-sulfotyrosine antibodies allow researchers to investigate the broader spectrum of tyrosine-sulfated proteins.

What are the validated applications for TPST1 antibodies?

TPST1 antibodies have been validated for multiple experimental applications, with specific recommendations for each technique:

Each application requires specific optimization, and manufacturers recommend titrating the antibody in each testing system to obtain optimal results .

How should I prepare samples for TPST1 immunohistochemistry?

For optimal TPST1 detection in tissue samples by IHC, follow these methodological steps:

• Fix tissues appropriately (typically 10% neutral buffered formalin) and embed in paraffin

• Section tissues at 4-6 μm thickness

• For antigen retrieval, use TE buffer at pH 9.0 (primary recommendation) or citrate buffer at pH 6.0 (alternative)

• Block endogenous peroxidase activity with hydrogen peroxide solution

• Perform protein blocking with normal serum or protein blocking solution

• Apply primary TPST1 antibody at 1:50-1:500 dilution (optimal dilution should be determined experimentally)

• Incubate at appropriate temperature and time (typically 4°C overnight or room temperature for 1-2 hours)

• Apply appropriate detection system (e.g., HRP-polymer) and develop with chromogen

• Counterstain, dehydrate, and mount

Positive controls such as human colon cancer tissue have been validated for certain TPST1 antibodies and should be included in experiments .

What is the proper procedure for using TPST1 antibodies in Western blotting?

For effective Western blot detection of TPST1:

• Prepare protein lysates from appropriate samples (A549 cells, mouse/rat heart tissue have been validated)

• Separate proteins using SDS-PAGE (expect TPST1 at approximately 42 kDa)

• Transfer proteins to a membrane (PVDF or nitrocellulose)

• Block with appropriate blocking buffer

• Incubate with primary TPST1 antibody at 1:500-1:2000 dilution

• Wash thoroughly with TBST or similar buffer

• Incubate with appropriate secondary antibody

• Wash thoroughly

• Develop using chemiluminescent detection system

For enhanced specificity, consider using positive controls (A549 cells) and negative controls (secondary antibody only) . The observation of a band at exactly 42 kDa confirms detection of TPST1 protein .

How can I distinguish between TPST1 and TPST2 activity in my experimental system?

Distinguishing between TPST1 and TPST2 activity requires a multifaceted approach:

• Antibody specificity: Use isoform-specific antibodies that do not cross-react between TPST1 and TPST2

• Knockout/knockdown models: Utilize TPST1 and TPST2 knockout or knockdown systems to identify isoform-specific substrates

• Substrate analysis: Research indicates that TPST1 and TPST2 have distinct macromolecular substrate specificities

• Comparative analysis: Western blot analysis using anti-sulfotyrosine antibodies (like PSG2) on samples from wild-type versus Tpst2(-/-) mice revealed that certain sperm/epididymal proteins are undersulfated in Tpst2(-/-) mice, indicating distinct substrate specificities

• Expression pattern analysis: Compare expression patterns of both isoforms in your tissue/cell type of interest

For critical analyses, combining multiple approaches provides more definitive results than relying on a single method.

What are the best practices for validating TPST1 antibody specificity?

Rigorous validation of TPST1 antibody specificity includes:

• Cross-reactivity assessment: Test the antibody against recombinant TPST1 and TPST2 proteins to ensure specificity

• Peptide competition: Pre-incubate the antibody with the immunizing peptide to confirm specific binding is blocked

• Knockout/knockdown controls: Use TPST1 knockout or knockdown samples as negative controls

• Multi-species validation: Confirm reactivity across relevant species (human, mouse, rat) as claimed

• Multi-technique validation: Verify consistent results across different applications (WB, IHC, IF)

• Epitope mapping: Understand which region of TPST1 the antibody recognizes (e.g., C-terminal AA 336-366, AA 283-370, etc.)

• Array validation: Some antibodies have been validated on protein arrays containing the target protein plus numerous non-specific proteins

Documenting these validation steps enhances the reliability and reproducibility of experimental results using TPST1 antibodies.

How do I design experiments to investigate TPST1-mediated protein sulfation pathways?

A comprehensive experimental strategy includes:

• Expression analysis: Determine TPST1 expression in your cell/tissue model using validated antibodies

• Activity assessment: Use anti-sulfotyrosine antibodies (e.g., PSG2) to detect sulfated proteins

• Functional modulation:

  • Overexpression of TPST1 to enhance sulfation

  • siRNA/shRNA-mediated knockdown to reduce sulfation

  • CRISPR-Cas9-mediated knockout for complete elimination

• Substrate identification:

  • Immunoprecipitation with anti-sulfotyrosine antibodies followed by mass spectrometry

  • Western blotting of potential substrates before and after modulating TPST1 levels

• Functional consequences:

  • Assess phenotypic changes after TPST1 modulation

  • Evaluate protein-protein interactions dependent on tyrosine sulfation

• Inhibitor studies: Use sodium chlorate to inhibit sulfation and evaluate consequences

• Comparative analysis: Compare with TPST2-mediated effects to distinguish isoform-specific pathways

This integrated approach allows for comprehensive mapping of TPST1-dependent sulfation networks and their biological significance.

What are common issues with TPST1 antibodies in Western blotting and how can they be resolved?

For optimal results, samples from A549 cells, mouse heart tissue, or rat heart tissue have been validated as positive controls for certain TPST1 antibodies . The expected molecular weight for TPST1 is 42 kDa .

How can I optimize TPST1 immunohistochemistry staining to reduce background and enhance specific signal?

To optimize TPST1 IHC:

• Antigen retrieval optimization:

  • Compare TE buffer (pH 9.0) with citrate buffer (pH 6.0)

  • Adjust retrieval time and temperature

• Antibody titration:

  • Test a range of dilutions (1:50-1:500) to find optimal concentration

  • Include positive control (human colon cancer tissue)

• Background reduction:

  • Extend blocking step duration

  • Add 0.1-0.3% Triton X-100 for balanced permeabilization

  • Use avidin/biotin blocking for biotin-conjugated systems

• Signal enhancement:

  • Try polymer-based detection systems

  • Optimize incubation times and temperatures

  • Consider tyramide signal amplification for low-abundance targets

• Counterstain optimization:

  • Adjust hematoxylin concentration and timing

  • Use lighter counterstaining for weak TPST1 signals

Each tissue type may require specific modifications to this protocol. Document all optimization steps for reproducibility.

How should I store and handle TPST1 antibodies to maintain their activity?

Proper handling and storage of TPST1 antibodies are crucial for maintaining reactivity:

• Storage temperature:

  • Store at -20°C for long-term storage

  • 4°C is suitable for short-term storage

  • Avoid repeated freeze-thaw cycles

• Aliquoting:

  • For antibodies without stabilizers, divide into small aliquots before freezing

  • Some TPST1 antibodies contain glycerol (50%) and don't require aliquoting for -20°C storage

• Buffer composition:

  • Most TPST1 antibodies are supplied in PBS with 0.02% sodium azide and 50% glycerol at pH 7.3

  • Some small-volume preparations (20μl) may contain 0.1% BSA

• Thawing procedure:

  • Thaw at room temperature or 4°C

  • Mix gently; avoid vortexing

• Working solution preparation:

  • Dilute immediately before use

  • Use high-quality diluents compatible with your application

• Stability information:

  • Most TPST1 antibodies remain stable for one year after shipment when stored properly

Following these guidelines helps ensure consistent antibody performance across experiments.

How do I interpret TPST1 expression patterns across different tissues and cell types?

When analyzing TPST1 expression:

• Tissue-specific patterns: Compare your findings with validated positive controls such as:

  • A549 cells for cell culture work

  • Mouse and rat heart tissue for animal studies

  • Human colon cancer tissue for human samples

• Subcellular localization: TPST1 is primarily localized to the Golgi apparatus; confirm this localization in your experimental system

• Expression level interpretation:

  • Quantify relative expression across samples

  • Normalize to appropriate housekeeping genes/proteins

  • Consider both protein (Western blot/IHC) and mRNA (qPCR) levels

• Functional correlation:

  • Correlate TPST1 expression with levels of tyrosine-sulfated proteins (detected using anti-sulfotyrosine antibodies)

  • Assess phenotypic consequences of expression variation

• Pathological significance:

  • Compare expression in normal versus disease states

  • Evaluate potential as a biomarker or therapeutic target

A comprehensive interpretation should integrate expression data with functional outcomes and disease relevance.

What can Western blot band patterns tell me about TPST1 post-translational modifications or isoforms?

Analysis of TPST1 Western blot patterns can reveal:

• Expected band: The primary TPST1 band should appear at approximately 42 kDa

• Higher molecular weight bands: May indicate:

  • Post-translational modifications (glycosylation, SUMOylation, etc.)

  • Protein complexes resistant to denaturation

  • Cross-reactivity with related proteins

• Lower molecular weight bands: Could represent:

  • Proteolytic cleavage products

  • Alternative splice variants

  • Degradation artifacts

• Multiple bands of similar intensity: Possible isoforms or highly related family members

• Verification strategies:

  • Peptide competition to confirm specificity

  • Comparison with different TPST1 antibodies targeting distinct epitopes

  • Analysis after enzymatic removal of specific modifications

  • Mass spectrometry for definitive identification

Careful controls and multiple detection methods enhance the reliability of band pattern interpretation.

How can TPST1 antibodies be used to investigate disease mechanisms related to protein tyrosine sulfation?

TPST1 antibodies enable multiple investigative approaches:

• Expression analysis in disease states:

  • Compare TPST1 levels in normal versus pathological tissues

  • Correlate expression with disease progression or prognosis

• Identification of disease-specific substrates:

  • Combine TPST1 manipulation with anti-sulfotyrosine detection

  • Identify differentially sulfated proteins in disease contexts

• Functional studies:

  • Modulate TPST1 expression/activity in disease models

  • Assess impact on disease phenotypes

• Mechanistic investigations:

  • Study how alterations in tyrosine sulfation affect protein-protein interactions

  • Examine cross-talk with other post-translational modifications

• Therapeutic target assessment:

  • Evaluate consequences of pharmacological inhibition

  • Identify biomarkers for patient stratification

• Model systems:

  • Compare findings from Tpst1-/- and Tpst2-/- models to distinguish isoform-specific contributions

  • Translate insights from cellular to animal models and human specimens

The use of highly specific anti-TPST1 antibodies combined with anti-sulfotyrosine antibodies like PSG2 provides complementary insights into both the enzyme and its cellular substrates in disease contexts.